CJC-1295 DAC Australia 5mg / 10mg

CJC-1295 DAC is the modified 29-amino-acid GHRH fragment with a drug affinity complex attached through an added lysine. The fragment acts at the GHRH receptor, and the DAC binds albumin so the molecule stays in circulation for days rather than hours.

DAC stands for drug affinity complex, a reactive group that bonds to albumin, the most abundant protein in blood. Because albumin circulates for weeks, the attached peptide is shielded from clearance, which is what gives CJC 1295 with DAC its long half-life.

You will see it written cjc 1295 dac, cjc-1295 dac, cjc 1295 with dac, cjc1295 dac and long-acting CJC-1295. In older literature the name CJC-1295 on its own often meant this DAC version specifically, so check which molecule a listing or paper describes.

They share the same modified GHRH fragment, but the DAC version binds albumin and lasts roughly a week, giving sustained receptor activation, while the No DAC form clears within hours and gives a pulsatile pattern closer to natural signalling. They are different molecules, and findings on one do not transfer to the other. PhaseOne stocks both. View CJC-1295 No DAC.

Published early human research reported a half-life of roughly six to eight days, with growth hormone and IGF-1 elevations lasting several days after a single administration. That is the defining difference from the No DAC form, whose half-life is measured in hours.

Yes. PhaseOne has CJC 1295 DAC for sale online in 5mg and 10mg vials, shipped Australia-wide from local stock. The thing worth checking on any listing is that it states DAC explicitly, since some listings use the name CJC-1295 without saying which form they sell. Every PhaseOne batch has its Certificate of Analysis published in our public COA library.

PhaseOne prices CJC-1295 DAC at A$76.99 for the 5mg vial and A$119.99 for 10mg, and the batch Certificate of Analysis is free to view in our public COA library. Current pricing is shown on this page.

CJC-1295 DAC is supplied in 5mg and 10mg vials of lyophilised powder, shipped Australia-wide with full batch documentation.

No. CJC-1295 is not registered on the ARTG and is not approved for supply as a medicine in Australia, so Chemist Warehouse and other Australian chemists do not stock it in either form. It is supplied as a research compound through research suppliers instead.

Both act at the GHRH receptor. Tesamorelin is a 44-amino-acid near-full-length GHRH analogue with a half-life in hours, while CJC-1295 DAC is a 29-amino-acid fragment whose albumin binding stretches its half-life to days. Compare with our Tesamorelin.

Sometimes, but the No DAC form is the more common partner, because its short window can be timed alongside Ipamorelin. With the DAC version the GHRH receptor signal is continuous, so the pairing answers a different research question. View our Ipamorelin or the CJC-1295 + Ipamorelin blend.

Unreconstituted CJC-1295 DAC should be stored refrigerated and protected from light, and is commonly reconstituted using bacteriostatic water prior to research preparation. Concentration tables for both vial sizes are in the CJC-1295 DAC research guide, and technique is covered in our reconstitution guide.

Every batch of CJC 1295 DAC sold across Australia by PhaseOne is independently HPLC tested, with a Certificate of Analysis confirming identity and purity. With this compound the identity result matters as much as the purity figure, because DAC and No DAC are sold under overlapping names.